Home > Income Statement > MARKSANS PHARMA

MARKSANS PHARMA
Consolidated Net Profit

    Back to Income Statement
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

MARKSANS PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹381 Cr₹314 Cr₹266 Cr₹185 Cr₹236 Cr

What is the latest Consolidated Net Profit of MARKSANS PHARMA ?

The latest Consolidated Net Profit ratio of MARKSANS PHARMA is ₹381 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹381 Cr
Mar2024₹314 Cr
Mar2023₹266 Cr
Mar2022₹185 Cr
Mar2021₹236 Cr

How is Consolidated Net Profit of MARKSANS PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹381 Cr
21.32
Mar2024 ₹314 Cr
17.80
Mar2023 ₹266 Cr
44.29
Mar2022 ₹185 Cr
-21.77
Mar2021 ₹236 Cr -

Compare Consolidated Net Profit of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹7,378.1 Cr 2.5% -7.6% -24% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,837.0 Cr 2.9% 3.6% 0.2% Stock Analytics
DIVIS LABORATORIES ₹159,175.0 Cr 0.6% -4.5% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,394.0 Cr 2.1% -0.4% 31.8% Stock Analytics
DR REDDYS LABORATORIES ₹106,999.0 Cr 2.2% -0.4% 6.2% Stock Analytics
CIPLA ₹100,379.0 Cr 0.4% -6.2% -19.4% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

2.5%

-7.6%

-24%

SENSEX

-0.8%

-11.7%

-3.6%


You may also like the below Video Courses